Abstract
Alpha-1-antitrypsin (AAT) is a circulating protein, a serpin, with multiple protective functions. Beside the well-known proteinase inhibitory function, which protects the lungs from chronic obstructive pulmonary disease (COPD), many studies have shown that AAT inhibits pro-inflammatory cytokine gene expression and functions. These anti-inflammatory and immune-regulatory properties have led to studies testing the therapeutic effect of AAT in autoimmune disease models. Initially, a study using recombinant adeno-associated viral (rAAV) vector showed that AAT gene therapy prevented type 1 diabetes (T1D) development in a nonobese diabetic (NOD) mouse model. Consequently, several studies confirmed that AAT therapy prevented and reversed T1D. AAT therapy has also been tested and has demonstrated protective effects in a collagen-induced arthritis model and a systemic lupus erythematosus (SLE) mouse model. This chapter describes methods that evaluate AAT functions in autoimmune mouse models.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bergin DA, Hurley K, McElvaney NG et al (2012) Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp 60:81–97
Perlmutter DH, Punsal PI (1988) Distinct and additive effects of elastase and endotoxin on expression of alpha 1 proteinase inhibitor in mononuclear phagocytes. J Biol Chem 263:16499–16503
Knoell DL, Ralston DR, Coulter KR et al (1998) Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med 157:246–255
Perlino E, Cortese R, Ciliberto G (1987) The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. EMBO J 6:2767–2771
Hafeez W, Ciliberto G, Perlmutter DH (1992) Constitutive and modulated expression of the human alpha 1 antitrypsin gene. Different transcriptional initiation sites used in three different cell types. J Clin Invest 89:1214–1222
Kalsheker N, Morley S, Morgan K (2002) Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 30:93–98
Miyamoto Y, Akaike T, Alam MS et al (2000) Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity. Biochem Biophys Res Commun 267:918–923
Macen JL, Upton C, Nation N et al (1993) SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology 195:348–363
Petrache I, Fijalkowska I, Zhen L, Medler TR et al (2006) An Antiapoptotic role for {alpha}1-antitrypsin in the prevention of emphysema. Proc Am Thorac Soc 3:549
Zhang B, Lu Y, Campbell-Thompson M et al (2007) Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 56:1316–1323
Petrache I, Fijalkowska I, Medler TR et al (2006) Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169:1155–1166
Petrache I, Fijalkowska I, Zhen L et al (2006) A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 173:1222–1228
Toldo S, Seropian IM, Mezzaroma E et al (2011) Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 51:244–251
Maes OC, Kravitz S, Mawal Y et al (2006) Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis 24:89–100
Bergink V, Gibney SM, Drexhage HA (2014) Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry 75:324–331
Frenzel E, Wrenger S, Brugger B et al (2015) Alpha1-antitrypsin combines with plasma fatty acids and induces angiopoietin-like protein 4 expression. J Immunol 195:3605–3616
Karnaukhova E (2010) Interactions of alpha1-proteinase inhibitor with small ligands of therapeutic potential: binding with retinoic acid. Amino Acids 38:1011–1020
Akbar MA, Nardo D, Chen MJ et al (2017) Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions. Mol Med 23. https://doi.org/10.2119/molmed.2016.00170
Grimstein C, Choi YK, Wasserfall CH et al (2011) Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. J Transl Med 9:21
Grimstein C, Choi YK, Satoh M et al (2010) Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis. J Gene Med 12:35–44
Lewis EC, Shapiro L, Bowers OJ et al (2005) Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci U S A 102:12153–12158
Collins CB, Aherne CM, Ehrentraut SF et al (2013) Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm Bowel Dis 19:1964–1973
Le HT, Hirko AC, Thinschmidt JS et al (2011) The protective effects of plasma gelsolin on stroke outcome in rats. Exp Transl Stroke Med 3:13
Akbar MA, Lu Y, Elshikha AS et al (2017) Transplantation of adipose tissue-derived mesenchymal stem cell (ATMSC) expressing alpha-1 antitrypsin reduces bone loss in ovariectomized osteoporosis mice. Hum Gene Ther 28:179–189
Akbar MA, Cao JJ, Lu Y et al (2016) Alpha-1 antitrypsin gene therapy ameliorates bone loss in ovariectomy-induced osteoporosis mouse model. Hum Gene Ther 27:679–686
Ma H, Lu Y, Li H et al (2010) Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Diabetologia 53:2198–2204
Elshikha AS, Lu Y, Chen MJ et al (2016) Alpha 1 antitrypsin inhibits dendritic cell activation and attenuates nephritis in a mouse model of lupus. PLoS One 11:e0156583
Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2:1269–1275
Perry D, Sang A, Yin Y et al (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:271694
Edwards CJ, Cooper C (2006) Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 143:1–5
Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121
Kumar Y, Bhatia A (2014) Detection of antinuclear antibodies in SLE. Methods Mol Biol 1134:37–45
Sang A, Zheng YY, Yin Y et al (2014) Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus. PLoS One 9:e102151
King C, Sarvetnick N (2011) The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 6:e17049
Lu Y, Parker M, Pileggi A et al (2008) Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. Clin Exp Immunol 154:15
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Song, S., Lu, Y., Elshikha, A.S. (2018). In Vivo Analysis of Alpha-1-Antitrypsin Functions in Autoimmune Disease Models. In: Lucas, A. (eds) Serpins. Methods in Molecular Biology, vol 1826. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8645-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8645-3_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8644-6
Online ISBN: 978-1-4939-8645-3
eBook Packages: Springer Protocols